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Background: The International Study Group for Pancreatic Surgery (ISGPS) has proposed several
definitions for postoperative pancreatic fistula (POPF), delayed gastric emptying (DGE) and post-
pancreatectomy haemorrhage (PPH). We assessed the effects of implementing these definitions on
predicting outcomes.
Methods: A database of 77 patients who underwent pancreaticoduodenectomy between January 2005
and December 2009 was analysed. Morbidities were defined and classified using the ISGPS definitions
and recalculated based on the definitions adopted by our institution (‘Old’ definitions) prior to the
implementation of ISGPS definitions. Data for the two groups were then compared.
Results: The morbidity rate rose to 70.1% from 27.2% when ISGPS rather than Old definitions were
used to define morbidities (P < 0.001). Incidences of DGE, POPF and PPH were 20.7%, 39.0% and
10.4%, respectively. Rates of DGE and POPF were significantly higher according to ISGPS definitions
than to Old definitions (20.7% vs. 5.2% [P = 0.001] and 39.0% vs. 15.6% [P = 0.004], respectively).
According to the ISGPS definitions, all of the 12 additional patients with DGE and 12 of the 18 additional
patients with POPF had grade A morbidities. Patients with ISGPS-defined morbidity had a longer
intensive care unit (ICU) stay, longer postoperative stay and longer total stay (P = 0.030, P = 0.007 and
P = 0.001, respectively).
Conclusions: The morbidity rate more than doubled when ISGPS definitions were applied (an additional
42.9% of patients demonstrated morbidities). The majority of patients with DGE and POPF had grade A
morbidities. The ISGPS definitions correlate well with ICU stay, postoperative stay and total length of stay.
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Introduction
Over the last three decades, many centres have reported improved
mortality rates in pancreaticoduodenectomy (PD), but morbidity
rates remain high.1–14 The wide variation in definitions for the
various complications that may occur following pancreatic surgery
has made comparison across different institutions difficult.1,15–34
The International Study Group for Pancreatic Surgery (ISGPS) has
proposed definitions and classifications for the common morbidi-
ties that occur after pancreatic surgery, namely, postoperative pan-
creatic fistula (POPF), delayed gastric emptying (DGE) and post-
pancreatectomy haemorrhage (PPH).15,35,36 The aim of this study
was to assess the effects on predicting outcomes of implementing
the ISGPS definitions compared with the classification system used
in this institution previously.
Materials and methods
A prospective database of all patients who underwent PD in our
institution between January 2005 and December 2009 was
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analysed retrospectively. The new ISGPS guidelines to define and
classify postoperative morbidities in pancreatic surgery were
adopted in early 2006. Morbidity rates in the same cohort of
patients were then recalculated using the systems of classifying
DGE, POPF and PPH that had been in use locally prior to the
implementation of the ISGPS definitions (‘Old’ definitions).
Patients defined as having suffered morbidity by either classifica-
tion were then identified. Outcomes measured were postoperative
intensive care unit (ICU) stay, high-dependency unit (HDU) stay,
length of hospital stay (LoS) and total length of stay (the sum of
the stay from initial admission and any readmissions within 30
days of discharge). The two systems of classification were then
compared to assess if the ISGPS definitions related to LoS param-
eters better than the definitions used in the previous classification
system.
Data were analysed using spss Version 15.0 (SPSS, Inc.,
Chicago, IL, USA) and stata Version 9.2 (StataCorp LP, College
Station, TX, USA). Statistical significance was assumed at a
P-value of <0.05. McNemar’s test was used to cross-tabulate
nominal data and the Mann–Whitney test was used for non-
parametric continuous parameters.
The preoperative selection and workup of patients undergoing
PD have been described previously.37 Operative techniques for PD,
including the classical Whipple procedure and pylorus-preserving
PD have been reported previously.38 The choice of the type of
pancreatic-enteric anastomosis is based on the surgeon’s prefer-
ence. In general, hepatopancreatobiliary (HPB) surgeons choose
to perform pancreaticojejunostomy (PJ), whereas upper gas-
trointestinal tract (UGI) surgeons prefer pancreaticogastrostomy.
A standard pancreatic surgery care pathway for postoperative
management in the wards was applied since 2005. Surgery was
performed by one of five surgeons (three HPB and two UGI
surgeons) during the study period. A single dose of 200 mcg of
subcutaneous sandostatin was administered during pancreatic
transaction. Subcutaneous sandostatin was then continued for 1
week postoperatively at a dose established by the consistency of
the pancreatic tissue as assessed during surgery. If the pancreas
was soft or the pancreatic duct measured < 3 mm, 200 mcg was
administered at 8-h intervals; otherwise 100 mcg was adminis-
tered at 8-h intervals.39 In the immediate postoperative period,
patients were maintained on a nil-by-mouth regime in which a
nasogastric tube (NGT) was used to facilitate passive drainage and
aspiration at 4-h intervals. Patients were allowed non-milk feeds if
their nasogastric output was < 100 ml on postoperative day (PoD)
1 and the NGT was removed on PoD 2 if output remained at
< 100 ml. Feeding was graduated as tolerated. In general, by PoD
3 or 4, patients had started on a solid diet.
All complications were documented clearly and graded accord-
ing to the ISGPS grading system when applicable (Tables 1–3).
The specific complications examined include DGE, POPF and
PPH.
Grade A DGE does not lead to any marked change in manage-
ment other than for minor disturbances that occur during the
return to intake of solid food.15 Grade A POPF has no clinical
impact and requires little change in management or deviation
from the normal clinical pathway.36 For the purposes of this study,
grade A DGE and POPF are therefore referred to as clinically
insignificant morbidities.
Prior to the definitions proposed by the ISGPS, morbidities
were defined according to a different system of classification. This
is compared with the ISGPS definitions in Table 4.
Perioperative mortality was defined as in-hospital death or
death within 30 days of surgery.
Results
Demography
A total of 77 patients underwent PD during the study period, 40 of
whom were male. Demographics, comorbidities and histology
data are shown in Table 5.
Overall, 46 patients (59.7%) underwent a pylorus-preserving
PD and the rest underwent a classical Whipple procedure. Pan-
creaticojejunostomy anastomosis was performed in 63 (81.8%)
patients and pancreaticogastrostomy was carried out in the rest.
The median duration of surgery was 580 min (range: 245–
945 min). Median estimated blood loss was 1000 ml (range: 300–
6000 ml). The median quantity of blood transfused was 2 units
(range: 1–4 units).
Median postoperative stay and total LoS were 10 days (range:
5–137 days) and 15 days (range: 5–150 days), respectively. Median
ICU stay was 1 day (range: 0–28 days) and median HDU stay was
3 days (range: 0–12 days). One patient had a long ICU stay of 28
Table 1 International Study Group for Pancreatic Surgery grading of delayed gastric emptying after pancreatic surgery
DGE grade NGT required Unable to tolerate
solid oral intake at:
Vomiting/gastric
distension
Use of
prokinetics
A 4–7 days or reinsertion after PoD 3 PoD 7 Yes/no Yes/no
B 8–14 days or reinsertion after PoD 7 PoD 14 Yes Yes
C >14 days or reinsertion after PoD 14 PoD 21 Yes Yes
DGE, delayed gastric emptying; NGT, nasogastric tube; PoD, postoperative day.
To exclude mechanical causes of abnormal gastric emptying, the patency of either the gastrojejunostomy or the duodenojejunostomy should be
confirmed by endoscopy or upper gastrointestinal gastrographin series.
Adopted from Wente et al.15
HPB 567
HPB 2011, 13, 566–572 © 2011 International Hepato-Pancreato-Biliary Association
days after developing severe pneumonia with Type II respiratory
failure and a burst abdomen postoperatively.
Median ICU, HDU and postoperative stays and total LoS in
patients with and without morbidities were compared using the
ISGPS and Old definitions. No differences were seen in ICU stay,
HDU stay, postoperative stay or total LoS between patients with
and without morbidities defined using the Old definitions. By
contrast, patients with morbidities defined using the ISGPS defi-
nitions had significantly higher ICU stay, postoperative stay and
total LoS (Table 6).
Overall morbidity rates according to the Old and the ISGPS
definitions are compared in Table 7. The increase in DGE that
emerged when ISGPS definitions were applied was caused solely
by grade A DGE.
Table 2 International Study Group for Pancreatic Surgery grading of postoperative pancreatic fistula after pancreatic surgery
Grade A Grade B Grade C
Clinical conditions Well Often well Appearing ill
Specific treatmenta No Yes/no Yes
US/CT (if obtained) Negative Negative/positive Positive
Persistent drainage (after 3 weeks)b No Usually yes Yes
Re-operation No No Yes
Death related to POPF No No Possibly yes
Signs of infections No Yes Yes
Sepsis No No Yes
Readmission No Yes/no Yes/no
aPartial (peripheral) or total parenteral nutrition, antibiotics, enteral nutrition, somatostatin analogue and/or minimal invasive drainage.
bWith or without a drain in situ.
US, ultrasonography; CT, computed tomography; POPF, postoperative pancreatic fistula.
Adopted from Bassi et al.36
Table 3 International Study Group for Pancreatic Surgery grading of post-pancreatectomy haemorrhage after pancreatic surgery
Grade Time of onset, location, severity
and clinical impact of bleeding
Clinical
condition
Diagnostic
consequence
Therapeutic
consequence
A Early, intra- or
extraluminal, mild
Well Observation, blood count, US
and, if necessary, CT
No
B Early, intra- or
extraluminal,
severe
Later, intra- or
extraluminal,
milda
Often well/intermediate,
very rarely
life-threatening
Observation, blood count, US,
CT, angiography, endoscopyb
Transfusion of fluid-blood,
intermediate care unit (or
ICU), therapeutic
endoscopy,b embolization,
relaparotomy for early PPH
C Late, intra- or
extraluminal,
severe
Severely impaired,
life-threatening
Angiography, CT, endoscopyb Localization of bleeding,
angiography and
embolization, (endoscopyb) or
relaparotomy, ICU
aLate, intra- or extraluminal, mild bleeding may not be immediately life-threatening to the patient but may be a warning sign of later severe
haemorrhage (‘sentinel bleed’) and is therefore grade B.
bEndoscopy should be performed when signs of intraluminal bleeding are present (melaena, haematemesis or blood loss via nasogastric tube).
US, ultrasonography; CT, computed tomography; ICU, intensive care unit; PPH, post-pancreatectomy haemorrhage.
Adopted from Wente et al.35
Table 4 Comparison of ‘Old’ and International Study Group for Pancreatic Surgery (ISGPS) definitions
Morbidity Old definition used prior to ISGPS implementation ISGPS definition
DGE NGT required beyond PoD 7
Failure to tolerate solid diet before PoD 14
NGT required beyond PoD 3
Failure to tolerate solid diet before PoD 7
POPF Clinically significant pancreatic leak with persistent pancreatic fluid drainage
or intra-abdominal collection requiring percutaneous drainage,
subsequently proven to be rich in amylase (>3 ¥ serum amylase)
Abdominal drain output of any measurable volume
of drain fluid on or after PoD 3 with an amylase
content >3 ¥ upper normal serum value
PPH All cases of postoperative haemorrhage All cases of postoperative haemorrhage
DGE, delayed gastric emptying; POPF, postoperative pancreatic fistula; PPH, post-pancreatectomy haemorrhage; NGT, nasogastric tube; PoD,
postoperative day.
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Using the ISGPS definition, an additional 18 patients were diag-
nosed with POPF. Of these, 12, five and one case were caused by
grades A, B and C POPF, respectively.
The prevalence of PPH was 10.4% (n = 8); the same definition
was employed both pre- and post-ISGPS implementation.
The overall mortality rate in the study population was 1.3%
(n = 1).
Discussion
Studies on morbidities post-PD have been hampered by the lack
of universally accepted definitions of the various postoperative
occurrences, which has prevented the accurate comparison of sur-
gical experiences among centres.1,15–34,40,41 In a bid to overcome this
problem, the ISGPS has proposed uniform definitions and classi-
fications for the common postoperative morbidities in pancreatic
surgery.15,35,36 The aim of this study was to analyse the implemen-
tation of the ISGPS definitions and to determine whether they
related better to outcomes than those previously used.
The morbidity rate in this cohort of patients more than
doubled from 27.2% to 70.1% when ISGPS definitions rather than
the previous (Old) definitions were used (i.e. an additional 42.9%
of patients demonstrated morbidities). This reflected the more
stringent ISGPS definitions for POPF and DGE. The high mor-
bidity rate associated with the ISGPS definitions should be inter-
preted with caution as most of these morbidities were grade A
cases that were not clinically significant; their exclusion resulted in
a morbidity rate of only 31.2%. The inclusion of grade A mor-
bidities in the ISGPS system of grading severity should be
reviewed. A potential benefit of including grade A morbidities is
that it heightens the index of suspicion in patients in whom they
are identified, which may result in early intervention before the
morbidity progresses to become clinically significant (grades B
and C). However, their inclusion may also lead to a lowered
threshold for instigating unnecessary investigations or proce-
dures, such as computed tomography (CT) scans or drainage
procedures. The clinical relevance and cost-effectiveness of con-
sidering grade A morbidities in clinical practice should be studied
because their inclusion leads to an inflated morbidity rate with no
proven clinical benefit. Nonetheless, compared with the previous
system, the ISGPS definitions for post-PD morbidities appear to
relate better to ICU stay, postoperative stay and total LoS.
However, this improvement may in part reflect the larger number
of patients defined as having complications, which increases the
statistical power of detecting differences between those with and
without morbidities.
Prior to the ISGPS era, rates of DGE in PD have been reported
to vary from 20% to 60%.12,42–46 In the current study, a further
15.5% of patients were found to have DGE when the ISGPS rather
than the Old definition was used (20.7% vs. 5.2%; P = 0.001). This
entire increase involved patients with grade A (clinically insignifi-
cant) DGE. The rate of DGE in the current study was lower than
those reported in recently published studies using the ISGPS defi-
nition, in which DGE rates ranged from 33.3% to 44.5%.16,47,48 By
contrast with patients in a Korean study, which demonstrated an
almost equal distribution between each grade of DGE,16 patients
with DGE in this study were predominantly grade A (12 of 16).
This may be explained by an aggressive policy of feeding progres-
sion post-PD as the grading of DGE proposed by the ISGPS clas-
sification is dependent on the length of time until the patient first
tolerates diet. A cautious approach in feeding progression may
thus falsely inflate the incidence and severity of DGE. Thus, dif-
fering strategies in feeding progression may potentially contribute
to differences in rates of DGE and may confound comparisons of
DGE rates across institutions.
In the present cohort, a further 23.4% of patients were found to
have POPF with the adoption of the ISGPS definition (39.0% vs.
15.6%; P = 0.004). Two-thirds of this increase was attributed to
those with grade A POPF. The figures for POPF were comparable
with those of other studies utilizing the ISGPS definition, in which
rates of POPF varied from 10.2% to 50.0% and those of clinically
significant POPF (grades B and C) ranged from 6.5% to
30.0%.17,49–51 By contrast with other studies in which the majority
of POPF was clinically significant, the vast majority of POPF cases
in the current study were clinically insignificant (22 of 30).17,50
Table 5 Demographic data for patients in the present study (n = 77)
Age, years, median (range) 66 (29–83)
Ethnic group, n (%)
Chinese 64 (83.1%)
Malay 3 (3.9%)
Indian 4 (5.2%)
Others 6 (7.8%)
Comorbidities, n (%)
0 13 (16.9%)
1 15 (19.5%)
2 14 (18.3%)
>2 35 (45.5%)
ASA status, n (%)
1 6 (7.8%)
2 34 (44.2%)
3 36 (46.8%)
4 1 (1.3%)
Histology, n (%)
Adenocarcinoma 53 (68.8%)
Chronic pancreatitis 3 (3.9%)
Mucinous tumours 9 (11.7%)
Serous tumours 0
Villous adenomas 0
Othersa 12 (15.6%)
aIncludes histological diagnoses such as benign strictures, neuroendo-
crine tumours, inflammatory myofibroblastic tumours, solid cystic papil-
lary neoplasms, sarcomas and cavernous lymphangiomas.
ASA, American Society of Anesthesiologists.
HPB 569
HPB 2011, 13, 566–572 © 2011 International Hepato-Pancreato-Biliary Association
This may reflect a higher threshold for ordering imaging modali-
ties post-PD compared with other institutions as health care costs
in our nation are predominantly self-funded. Thus, fewer clini-
cally insignificant peripancreatic collections requiring CT scans
for diagnosis (grade B POPF) are detected, with the result that
more POPF patients are classified as having grade A rather than
grade B POPF. Thus, different patterns in resource utilization may
potentially influence the severity grading of POPF.
Conclusions
Using the ISGPS definitions of post-PD morbidities caused the
morbidity rate in this study cohort to more than double from
27.2% to 70.1% (i.e. an additional 42.9% of patients demon-
strated morbidities). The majority of patients with DGE and
POPF had grade A morbidities. The ISGPS definitions correlate
well with ICU stay, postoperative stay and total LoS.
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